semaglutide soul trial oral cardiovascular outcomes soul trial results Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes soul trial oral semaglutide cardiovascular

An in vitro cell experiment showed that phenylephrine, by stimulating -adrenergic receptors, increases intracellular Ca levels, thereby promoting metabolic processes such as glycogenolysis and gluconeogenesis

Using it consistently during the GLP-1 window builds the pattern before the drug's appetite suppression ends

Its not a steroid and wont directly increase muscle size without training stimulus

Otsuka, M., Kato, N., Ichimura, T., Abe, S., Tanaka, Y., Taniguchi, H., Hoshida, Y., Moriyama, M., Wang, Y., Shao, R., Narayan, D., Muroyama, R., Kanai, F., Kawabe, T., Isobe, T., & Omata, M

Cell Physiol Biochem 35(4):13351346